Goodova 50 Capsule is a combination pharmaceutical formulation containing Clomiphene citrate 50 mg and Melatonin 3 mg, designed to address specific reproductive and circadian rhythm disorders. Clomiphene citrate is a selective estrogen receptor modulator (SERM) primarily used to induce ovulation in anovulatory women, particularly those with polycystic ovary syndrome (PCOS), by stimulating the release of gonadotropins (LH and FSH) from the pituitary gland. Melatonin, a naturally occurring hormone produced by the pineal gland, regulates the sleep-wake cycle and exhibits antioxidant properties. The inclusion of melatonin in this formulation supports the normalization of circadian rhythms and may enhance reproductive function by modulating hormonal balance and improving sleep quality. Goodova 50 Capsule is indicated for women experiencing infertility related to ovulatory dysfunction and those with disrupted sleep patterns that may impact reproductive health. The combined action of Clomiphene and Melatonin aims to optimize ovulation induction while supporting overall endocrine and circadian system stability. This medication should be used under medical supervision, with appropriate monitoring of ovulatory response and hormonal levels. Contraindications include known hypersensitivity to either component, liver disease, uncontrolled thyroid or adrenal dysfunction, and pregnancy. Patients should be advised regarding potential side effects such as hot flashes, visual disturbances, mood changes, and drowsiness.